Ethnicity and age disparities in Ewing sarcoma outcome

REFERENCES

• Fletcher C, Unni KK, Mertens F. World Health Organization classification of tumours: pathology and genetics of tumours of soft tissue and bone. Lyons, France: IARC Press; 2002.
   Google Scholar
• Pinto A, Dickman P, Parham D. Pathobiologic markers of the ewing sarcoma family of tumors: state of the art and prediction of behaviour. Sarcoma 2011:856190, 2011. doi: 10.1155/2011/856190
   Google Scholar
• Jawad MU, Cheung MC, Min ES, Ewing sarcoma demonstrates racial disparities in incidence-related and sex-related differences in outcome: an analysis of 1631 cases from the SEER database, 1973–2005. Cancer 115(15):3526–3536, 2009.
   PubMed Web of Science ®Google Scholar
• Lee J, Hoang BH, Ziogas A, Analysis of prognostic factors in Ewing sarcoma using a population-based cancer registry. Cancer 116(8):1964–1973, 2010.
   PubMed Web of Science ®Google Scholar
• De Angulo G, Hernandez M, Morales-Arias J, Early lymphocyte recovery as a prognostic indicator for high-risk Ewing sarcoma. J Pediat Hematol Oncol 29(1):48–52, 2007.
   PubMed Web of Science ®Google Scholar
• Worch J, Matthay KK, Neuhaus J, Ethnic and racial differences in patients with Ewing sarcoma. Cancer 116(4):983–988, 2010.
   PubMed Web of Science ®Google Scholar
• Fraumeni JF, Jr., Glass AG. Rarity of Ewing's sarcoma among U.S. Negro children. Lancet 1(7642):366–367, 1970.
   Google Scholar
• Li FP, Tu JT, Liu FS, Rarity of Ewing's sarcoma in China. Lancet 1(8180):1255, 1980.
   Google Scholar
• Parkin DM, Stiller CA, Nectoux J. International variations in the incidence of childhood bone tumours. Int J Cancer 53(3):371–376, 1993.
   Web of Science ®Google Scholar
• Martin RC, 2nd, Brennan MF. Adult soft tissue Ewing sarcoma or primitive neuroectodermal tumors: predictors of survival? Arch Surg 138(3):281–285, 2003.
   Google Scholar
• Sinkovics JG, Plager C, Ayala AG, Ewing sarcoma: its course and treatment in 50 adult patients. Oncology 37(2):114–119, 1980.
   Google Scholar
• Bacci G, Forni C, Longhi A, Long-term outcome for patients with non-metastatic Ewing's sarcoma treated with adjuvant and neoadjuvant chemotherapies: 402 patients treated at Rizzoli between 1972 and 1992. Eur J Cancer 40(1):73–83, 2004.
   Google Scholar
• Verrill MW, Judson IR, Harmer CL, Ewing's sarcoma and primitive neuroectodermal tumor in adults: are they different from Ewing's sarcoma and primitive neuroectodermal tumor in children? J Clin Oncol 15(7):2611–2621, 1997.
   Web of Science ®Google Scholar
• Yamada K, Sugiura H, Takahashi M. Single center experience of treatment of Ewing's family of tumors in Japan. J Orthop sci 11(1):34–41, 2006.
   Google Scholar
• Bacci G, Balladelli A, Forni C, Adjuvant and neoadjuvant chemotherapy for Ewing sarcoma family tumors in patients aged between 40 and 60: report of 35 cases and comparison of results with 586 younger patients treated with the same protocols in the same years. Cancer 109:780–786, 2007.
   Google Scholar
• Bhatia S. Influence of race and socioeconomic status on outcome of children treated for childhood acute lymphoblastic leukemia. Curr Opin Pediatr 16(1):9–14, 2004.
   Google Scholar
• Bhatia S, Sather HN, Heerema NA, Racial and ethnic differences in survival of children with acute lymphoblastic leukemia. Blood 100(6):1957–1964, 2002.
   PubMed Web of Science ®Google Scholar
• Kadan-Lottick NS, Ness KK, Bhatia S, Gurney JG. Survival variability by race and ethnicity in childhood acute lymphoblastic leukemia. JAMA 290(15):2008–2014, 2003.
   PubMed Web of Science ®Google Scholar
• Linabery AM, Ross JA. Childhood and adolescent cancer survival in the US by race and ethnicity for the diagnostic period 1975-1999. Cancer 113(9):2575–2596, 2008.
   PubMed Web of Science ®Google Scholar
• Castellino SM, Casillas J, Hudson MM, Minority adult survivors of childhood cancer: a comparison of long-term outcomes, health care utilization, and health-related behaviors from the childhood cancer survivor study. J Clinic oncol 23(27):6499–6507, 2005.
   Google Scholar
• Oberlin O, Deley MC, Bui BN, Prognostic factors in localized Ewing's tumours and peripheral neuroectodermal tumours: the third study of the French Society of Paediatric Oncology (EW88 study). Brit J cancer 85(11):1646–1654, 2001.
   Web of Science ®Google Scholar
• Burroughs V, Maxey R, Levy R. Racial and ethnic differences in response to medicines: Towards individualized pharmaceutical treatment. J Natl Med Assoc 94(10):1–26, 2002.
   PubMed Web of Science ®Google Scholar
• Urban T. Race, ethnicity, ancestry, and pharmacogenetics. MS J Medicine 77:133–139, 2010.
   Google Scholar
• Jones D. How personalized medicine became genetic, and racial: werner kalow and the formations of pharmacogenetics. J Hist Med All Sci 2011.
   Google Scholar
• Esiashvili N, Goodman M, Marcus RB, Jr. Changes in incidence and survival of Ewing sarcoma patients over the past 3 decades: surveillance epidemiology and end results data. J Pediat Hematol Oncol 30(6):425–430, 2008.
   PubMed Web of Science ®Google Scholar
• Paulussen M, Ahrens S, Dunst J, Localized Ewing tumor of bone: final results of the cooperative Ewing's Sarcoma Study CESS 86. J Clin Oncol 19(6):1818–1829, 2001.
   Web of Science ®Google Scholar
• Sauer R, Jurgens H, Burgers JM, Prognostic factors in the treatment of Ewing's sarcoma. The Ewing's Sarcoma Study Group of the German Society of Paediatric Oncology CESS 81. Radiother Oncol 10(2):101–110, 1987.
   Google Scholar
• Zang J, Guo W, Yang RL,et al.. [Ewing's sarcoma of bone:treatment results and prognostic factors]. Zhonghua wai ke za zhi [Chinese J Surg] 48(12):896–899, 2010.
   Google Scholar
• Bacci G, Ferrari S, Longhi A, Prognostic significance of serum LDH in Ewing's sarcoma of bone. Oncol Rep 6(4):807–811, 1999.
   Google Scholar